You May Also Like
Orphalan announces US commercial launch of Cuvrior™ for the treatment of Wilson disease
adminApril 20, 2023
Podcast: Naseem Amin, Orphalan CEO, discusses Wilson’s Disease and the potential advancements in its treatments on DNA Today
adminFebruary 6, 2023